These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16466730)

  • 1. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.
    Durst R; Jansen A; Erez G; Bravdo R; Butbul E; Ben Avi L; Shpitzen S; Lotan C; Leitersdorf E; Defesche J; Friedlander Y; Meiner V; Miserez AR
    Atherosclerosis; 2006 Dec; 189(2):443-50. PubMed ID: 16466730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction.
    Friedlander Y; Schwartz SM; Durst R; Meiner V; Robertson AS; Erez G; Leitersdorf E; Siscovick DS
    Atherosclerosis; 2008 Feb; 196(2):896-904. PubMed ID: 17383658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia.
    Miserez AR; Muller PY; Barella L; Barella S; Staehelin HB; Leitersdorf E; Kark JD; Friedlander Y
    Atherosclerosis; 2002 Sep; 164(1):15-26. PubMed ID: 12119189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
    Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
    Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
    Jensen KK; Tadin-Strapps M; Wang SP; Hubert J; Kan Y; Ma Y; McLaren DG; Previs SF; Herath KB; Mahsut A; Liaw A; Wang S; Stout SJ; Keohan C; Forrest G; Coelho D; Yendluri S; Williams S; Koser M; Bartz S; Akinsanya KO; Pinto S
    J Lipid Res; 2016 Dec; 57(12):2150-2162. PubMed ID: 27707816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children.
    Liu FH; Song JY; Shang XR; Meng XR; Ma J; Wang HJ
    Biomed Res Int; 2014; 2014():538564. PubMed ID: 25028659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.
    Li J; Nanayakkara A; Jun J; Savransky V; Polotsky VY
    Physiol Genomics; 2007 Oct; 31(2):273-80. PubMed ID: 17666524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys.
    Murphy BA; Tadin-Strapps M; Jensen K; Mogg R; Liaw A; Herath K; Bhat G; McLaren DG; Previs SF; Pinto S
    Metabolism; 2017 Jun; 71():202-212. PubMed ID: 28521874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene.
    Nakajima T; Hamakubo T; Kodama T; Inazawa J; Emi M
    J Hum Genet; 1999; 44(6):402-7. PubMed ID: 10570913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells.
    Choi MC; Lee YU; Kim SH; Lee JH; Park JH; Streb JW; Oh DY; Im SA; Kim TY; Jong HS; Bang YJ
    Int J Biochem Cell Biol; 2008; 40(11):2534-43. PubMed ID: 18579430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.
    Salek L; Lutucuta S; Ballantyne CM; Gotto AM; Marian AJ
    J Mol Med (Berl); 2002 Nov; 80(11):737-44. PubMed ID: 12436350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study.
    Garcia-Rios A; Perez-Martinez P; Mata P; Fuentes F; Lopez-Miranda J; Alonso R; Caballero J; Mata N; Perez-Jimenez F; Ordovas JM
    Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):957-63. PubMed ID: 20692138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional promoter polymorphism in SREBP cleavage-activating protein (SCAP).
    Cao H; Miskie BA; Hegele RA
    J Hum Genet; 2002; 47(9):492-6. PubMed ID: 12202990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP.
    Shimizu-Albergine M; Van Yserloo B; Golkowski MG; Ong SE; Beavo JA; Bornfeldt KE
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5685-93. PubMed ID: 27601673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH).
    Soufi M; Ruppert V; Kurt B; Schaefer JR
    Gene; 2012 May; 499(1):218-22. PubMed ID: 22425645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of a key regulator of lipid homeostasis, Scap, promotes respiration in prostate cancer cells.
    Prabhu AV; Krycer JR; Brown AJ
    FEBS Lett; 2013 Apr; 587(7):983-8. PubMed ID: 23454642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.